|
Amgen is among the biggest of the biotech big'uns, and it's determined to get even bigger. The company uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. Anti-anemia drugs Epogen and Aranesp account for more than one-third of its sales. Enbrel, another leading drug, treats rheumatoid arthritis and is one of the best-selling drugs in this multi-billion-dollar market. The company has a promising drug pipeline and marketing alliances with Japanese brewer and drugmaker Kirin, Johnson & Johnson, and other pharmaceutical companies. Amgen sells its products primarily through wholesale distributors in North America and Europe.
|
| | | Contact Information | |
Address: |
1 Amgen Center Dr.
Thousand Oaks, CA 91320-1799
| | Phone: | 805-447-1000 | | Fax: | 805-447-1010 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 15003.00 M | | Revenue Growth (1 yr): | 1.60% | | Employees (2008): | 16,900 | | Employee Growth (1 yr): | (-3.40%) |
|
|
Key People
| | • |
Chairman, President, and CEO:
Kevin W. Sharer
| | • |
EVP Operations:
Fabrizio Bonanni
| | • |
EVP and CFO:
Robert (Bob) Bradway
|
|
|
